Literature DB >> 21772033

Uncovering the role of invariant chain in controlling MHC class II antigen capture.

Ronald N Germain1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21772033      PMCID: PMC3142091          DOI: 10.4049/jimmunol.1101663

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  31 in total

1.  Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs.

Authors:  P G GELL; B BENACERRAF
Journal:  Immunology       Date:  1959-01       Impact factor: 7.397

2.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

4.  Interaction between a "processed" ovalbumin peptide and Ia molecules.

Authors:  S Buus; S Colon; C Smith; J H Freed; C Miles; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Detection of a common polypeptide chain in I--A and I--E sub-region immunoprecipitates.

Authors:  P P Jones; D B Murphy; D Hewgill; H O McDevitt
Journal:  Mol Immunol       Date:  1979-01       Impact factor: 4.407

6.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

7.  Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.

Authors:  R Busch; I Cloutier; R P Sékaly; G J Hämmerling
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

Review 8.  The immune response genes of the major histocompatibility complex.

Authors:  B Benacerraf; R N Germain
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

9.  Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes.

Authors:  K Ziegler; E R Unanue
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

10.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  7 in total

1.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

2.  Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.

Authors:  Stefania Capone; Mariarosaria Naddeo; Anna Morena D'Alise; Adele Abbate; Fabiana Grazioli; Annunziata Del Gaudio; Mariarosaria Del Sorbo; Maria Luisa Esposito; Virginia Ammendola; Gemma Perretta; Alessandra Taglioni; Stefano Colloca; Alfredo Nicosia; Riccardo Cortese; Antonella Folgori
Journal:  Mol Ther       Date:  2014-01-30       Impact factor: 11.454

3.  Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.

Authors:  Olesya Chornoguz; Alexei Gapeev; Michael C O'Neill; Suzanne Ostrand-Rosenberg
Journal:  Mol Cell Proteomics       Date:  2012-08-31       Impact factor: 5.911

4.  Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.

Authors:  Brady J Hurtgen; Chiung-Yu Hung; Gary R Ostroff; Stuart M Levitz; Garry T Cole
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

Review 5.  MIF-Dependent Control of Tumor Immunity.

Authors:  Jordan T Noe; Robert A Mitchell
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

6.  Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain.

Authors:  Loulieta Nazerai; Søren Buus; Anette Stryhn; Allan Randrup Thomsen; Jan Pravsgaard Christensen
Journal:  Viruses       Date:  2021-11-03       Impact factor: 5.048

7.  Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

Authors:  Alexandra J Spencer; Matthew G Cottingham; Jennifer A Jenks; Rhea J Longley; Stefania Capone; Stefano Colloca; Antonella Folgori; Riccardo Cortese; Alfredo Nicosia; Migena Bregu; Adrian V S Hill
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.